How to Avoid Payment Suspension After a Hospice Survey

Introduction: The Stakes of a Hospice Survey Finding

For most hospice agencies, Medicare is the primary payer — typically representing 85 to 95 percent of total revenue. This financial reality means that a serious finding from a CMS hospice survey can threaten not just regulatory standing but the agency's very ability to operate. Among the most severe enforcement consequences CMS may impose on a noncompliant hospice is payment suspension — the immediate halt of Medicare payments while the agency is evaluated for serious compliance failures.

Payment suspension is not limited to egregious cases. CMS may impose payment suspension when an agency has a Condition-level deficiency that poses immediate jeopardy to patients, when an agency fails to submit an acceptable plan of correction within the required timeframe, when an agency fails to achieve substantial compliance within the timeframe established by CMS, or when CMS determines that a hospice poses a significant financial risk to the Medicare program. Understanding the pathway from survey findings to payment suspension — and how to interrupt it — is critical knowledge for every hospice administrator and compliance professional.

Understanding Condition-Level vs. Standard-Level Deficiencies

Not all survey deficiencies carry the same enforcement risk. CMS categorizes hospice deficiencies by their scope and severity. Standard-level deficiencies represent noncompliance with individual standards within a Condition of Participation but do not represent a failure of the entire Condition. Condition-level deficiencies represent a broader failure of an entire CoP, typically indicating systemic noncompliance that poses a meaningful risk to patients.

When a hospice receives a Condition-level deficiency, CMS initiates a compliance timeline that requires the agency to submit a plan of correction and achieve substantial compliance within a defined period. Failure to meet these timelines can trigger termination proceedings or, in some circumstances, payment suspension. Immediate jeopardy findings — the most severe category — may result in immediate payment suspension without the typical corrective action window.

Responding to Survey Findings: The Plan of Correction

The plan of correction is the agency's formal written response to survey deficiencies, submitted to the state survey agency and CMS. It is a legal document that commits the agency to specific corrective actions within specific timeframes. An effective plan of correction does several things.

• Acknowledges the deficiency clearly without minimizing or disputing the finding in a way that suggests the agency does not understand its compliance obligation.

• Identifies the root cause of the deficiency, demonstrating that the agency has investigated why the failure occurred and not just what occurred.

• Describes specific corrective actions including policy revisions, staff training, supervisory changes, audit activities, and system modifications.

• Establishes realistic but urgent completion dates that demonstrate the agency is taking the matter seriously.

• Identifies how the corrective actions will be monitored to ensure sustained compliance.

Many agencies make the mistake of submitting generic or vague plans of correction that fail to convince CMS that the underlying cause of the deficiency has been addressed. CMS may reject an unacceptable plan of correction and reissue the deficiency finding, extending the compliance timeline and increasing enforcement risk.

The Corrective Action Implementation Phase

Submitting a plan of correction is not sufficient. The agency must actually implement the corrective actions described in the plan and document implementation thoroughly. During the implementation phase, agencies should create a project management tracker that assigns each corrective action to a responsible individual with a due date, conduct the training activities described in the plan and document attendance, revise and implement the policies described in the plan, complete the audit activities described in the plan and retain audit documentation, and ensure that clinical leadership can demonstrate knowledge of the changes made when surveyors return for a revisit.

The Revisit Survey

After an agency submits a plan of correction for a Condition-level deficiency, CMS will typically schedule a revisit survey to determine whether the agency has achieved substantial compliance. The revisit is focused specifically on the deficiency areas identified in the initial survey. If the revisit finds that the agency has not achieved substantial compliance, CMS may initiate termination proceedings or impose payment suspension.

Preparing for a revisit requires the same rigor as preparing for an initial survey, with the added pressure of a narrow compliance focus. The agency must be able to demonstrate through documentation, staff interviews, and observed practice that the systemic failures identified in the initial survey have been corrected and that monitoring systems are in place to prevent recurrence.

Immediate Jeopardy: The Highest-Risk Scenario

An immediate jeopardy finding represents CMS's determination that the agency's noncompliance has placed or is likely to place patients in a situation that could result in serious injury, harm, impairment, or death. Immediate jeopardy triggers an accelerated enforcement timeline in which the agency must abate the immediate jeopardy rapidly — often within days — or face immediate payment suspension or termination.

Agencies facing an immediate jeopardy finding should take the following steps immediately: notify the agency's attorney and compliance consultant, assemble the clinical leadership team to assess the scope of the patient safety concern and implement immediate interventions, develop and submit an immediate jeopardy removal plan that addresses the specific patient safety issue identified, and communicate transparently with surveyors about the steps being taken to protect patients.

Proactive Strategies to Prevent Payment Suspension Risk

The best protection against payment suspension is a culture of compliance that prevents serious deficiencies from arising in the first place. Key proactive strategies include the following.

• Conduct annual mock surveys using a structured tool that mirrors actual CMS survey protocols, and use findings to drive QAPI projects.

• Maintain an active internal audit program that monitors compliance with the most frequently cited CoPs on a monthly basis.

• Invest in ongoing clinical staff education, with particular emphasis on plan of care quality, IDG documentation, and physician certification requirements.

• Respond promptly and completely to any informal survey concerns or complaint investigations, treating each as an opportunity to demonstrate compliance before a formal finding is made.

• Maintain a relationship with an experienced healthcare compliance consultant who can provide rapid response support when a survey or enforcement action is imminent.

How HealthBridge Can Help

Navigating the complexities of home health, hospice, assisted living, FQHC operations, or any healthcare regulatory environment requires experienced partners who understand the landscape. HealthBridge offers comprehensive consulting and management solutions tailored to healthcare providers at every stage — whether you are launching a new agency, responding to a survey deficiency, defending an audit, or building long-term operational excellence.

HealthBridge consultants bring hands-on expertise in regulatory compliance, clinical documentation, QAPI design, survey preparation, billing defense, staff training, and strategic operations. From start-up licensing to complex audit defense, HealthBridge provides the guidance, tools, and support your organization needs to succeed.

Contact HealthBridge today to learn how their consulting and management solutions can protect your agency, elevate your care quality, and position you for long-term regulatory and financial success.

References

https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-418
https://www.cms.gov/files/document/cms-hospice-conditions-participation.pdf
https://www.cms.gov/files/document/hospice-interpretive-guidelines.pdf
https://www.cms.gov/medicare/provider-enrollment-and-certification/certificationandcomplianc
https://www.cms.gov/files/document/qso-21-08-hospice.pdf
https://www.cms.gov/files/document/qso-19-09-hospice.pdf